Journal of Korean Medicine for Obesity Research (한방비만학회지)

The Society of Korean Medicine for obesity Research (한방비만학회)
권호 표지
DOI QR코드

DOI QR Code

Herbal Medicine with Diet Control and Exercise for Class III Obesity: A Case Report

단일 한의 중재로서의 한약 및 일상 관리로 호전된 Class III 비만: 증례 보고

  • Han, Ye Ji (Dongshin Korean Medicine Hospital) ;
  • Cha, Jiyun (Digital Health Research Division, Korea Institute of Oriental Medicine)
  • 한예지 (동신한방병원) ;
  • 차지윤 (한국한의학연구원 디지털임상연구부)
  • Received : 2021.10.16
  • Accepted : 2021.11.19
  • Published : 2021.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

This study is reporting the clinical effect of herbal medicine for Class III obesity. A 34-year-old man with body mass index (BMI) 44.1 kg/m2 was diagnosed to Class III obesity. We prescribed herbal medicine (Gambi-hwan) for 60 days. Self controlled low calorie diet and slight aerobic exercise were concomitantly performed during the treatment period. Body weight decreased from 152.4 kg to 128.1 kg. BMI decreased from 44.1 kg/m2 to 37.0 kg/m2. Visceral fat area decreased from 276 cm2 to 195 cm2. Percent of excess weight loss was 58.40% after treatment. A Class III obesity patient showed significant weight loss with herbal medicine as single Korean medicine treatment.

Keywords

Acknowledgement

본 연구는 한국한의학연구원 연구 과제의 지원에 의하여 이루어졌음(KSN2021210).

References

  1. Backholer K, Wong E, Freak-Poli R, Walls HL, Peeters A. Increasing body weight and risk of limitations in activities of daily living: a systematic review and meta-analysis. Obes Rev 2012 ; 13(5) : 456-68. https://doi.org/10.1111/j.1467-789X.2011.00970.x
  2. Maniar RN, Maniar PR, Singhi T, Gangaraju BK. WHO class of obesity influences functional recovery post-TKA. Clin Orthop Surg. 2018 ; 10(1) : 26-32. https://doi.org/10.4055/cios.2018.10.1.26
  3. Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, et al. Body-mass index and mortality in Korean men and women. N Engl J Med. 2006 ; 355 : 779-87. https://doi.org/10.1056/NEJMoa054017
  4. O'Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obesity Surgery. 2019 ; 29(1) : 3-14. https://doi.org/10.1007/s11695-018-3525-0
  5. Kim KG. Safety of anti-obesity drugs approved for long-term use. The Korean Journal of Obesity. 2015 ; 24(1) : 17-27. https://doi.org/10.7570/kjo.2015.24.1.17
  6. Lee YJ, Hwang DS, Kim YS, Lee KS, A case study on a visceral fat changes in obese patient treated by the oriental medical therapy program, J Korean Med Obes Res. 2007 ; 7 : 97-106.
  7. Han HJ, Kim HJ, Park EJ, Jang JA, An TH, Seo HS, et al. The effect of oriental obesity therapy on Morbid obese patient with type 2 diabetes: two cases report. J Korean Med Obes Res. 2010 ; 10 : 57-63.
  8. Kim SH, Han KS, Kwon OJ, Lee WG, Yoon CS, Lee JH. Effect of Korean medicine treatment including Korean medicine counselling on weight loss in patients with morbid obesity: a retrospective chart review. J Korean Med Obes Res. 2021 ; 21 : 22-31. https://doi.org/10.15429/jkomor.2021.21.1.22
  9. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, CARE Group. The CARE guidelines: consensus-based clinical case report guideline development. Journal of Clinical Epidemiology. 2014 ; 67(1) : 46-51. https://doi.org/10.1016/j.jclinepi.2013.08.003
  10. National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03 [Internet]. 2016 [cited Jan 27, 2017]. Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf.
  11. Uppsala Monitoring Centre. The use of the WHO-UMC system for standardized case causality assessment [Internet]. 2018 [cited Apr 6, 2018]. Available from: http://who-umc.org/Graphics/24734.pdf.
  12. Na YK, Hong HS, Suk HJ. Blood biochemical parameters, physical activity, stress and sleep management by body mass index. J Korean Biol Nurs Sci. 2014 ; 16(2) : 133-40. https://doi.org/10.7586/jkbns.2014.16.2.133
  13. Heo YS, Kown JW, Lee HJ, Song HJ, Oh SH, Lee JY, et al. The clinical effectiveness and economic analysis of bariatric surgery for severe obesity. Seoul : National Evidence-based Healthcare Collaborating Agency Research report. 2011.
  14. Kim JH, Wolfe B. Bariatric/metabolic surgery: shortand long-term safety. Curr Atheroscler Rep. 2012 ; 14 : 597-605. https://doi.org/10.1007/s11883-012-0287-3
  15. James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2013 ; 363(10) : 905-17.
  16. Almandoz JP, Xie L, Schellinger JN, Mathew MS, Gazda C, Kukreja S, et al. Impact of COVID-19 stay-at-home orders on weight-related behaviours among patients with obesity. Clinical Obesity. 2020 ; 10(5) : e12386.
  17. Lohnberg JA, Salcido L, Frayne S, Mahtani N, Bates C, Hauser ME, et al. Rapid conversion to virtual obesity care in COVID-19: Impact on patient care, interdisciplinary collaboration, and training. Obesity Science & Practice. 2021 ; 1-6.
  18. Han KS, Kim SH. A study on the counseling practice for obesity in Korean medicine clinics and the satisfaction for counseling manual for the standardized management of obesity in Korean medicine. Journal of Korean Medicine for Obesity Research. 2020 ; 20(2) : 131-7. https://doi.org/10.15429/jkomor.2020.20.2.131
  19. Hwang MJ, Shin HD, Song MY. Review of literature on herbal medicines for the treatment of obesity in Korea - mainly papers since 2000. Journal of Oriental Rehabilitation Medicine. 2006 ; 16(3) : 65-82.
  20. Yoon SH, Lee EJ, Jo HJ, Han YJ, Kim HH, Yun YH, et al. Effect and safety of combined treatment of Gambihwan and Garcinia Cambogia on weight loss: a retrospective observational study, J Korean Med Obes Res. 2020 ; 20 : 31-9. https://doi.org/10.15429/jkomor.2020.20.1.31
  21. Sullivan S, Swain J, Woodman G, Edmundowicz S, Hassanein T, Shayani V, et al. Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss. Surg Obes Relat Dis. 2018 ; 14 : 1876-89. https://doi.org/10.1016/j.soard.2018.09.486
  22. Lopez-Nava G, Galvao MP, da Bautista-Castano I, Jimenez A, Grado TD, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy. 2015 ; 47 : 449-52. https://doi.org/10.1055/s-0034-1390766
  23. Lopez-Nava G, Bautista-Castano I, Jimenez A, de Grado T, Fernandez-Corbelle JP. The primary obesity surgery endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis. 2015 ; 11 : 861-5. https://doi.org/10.1016/j.soard.2014.09.026
  24. Lopez-Nava Breviere G, Bautista-Castano I, Fernandez-Corbelle JP, Trell M. Endoscopic sleeve gastroplasty (the Apollo method): a new approach to obesity management. Rev Esp Enferm Dig. 2016 ; 108 : 201-6.